Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price


About Talis Biomedical

Talis Bio (NASDAQ: TLIS) is developing a high-performance molecular point-of-care (POC) diagnostic platform to enable physician offices and clinics to run reference lab-quality diagnostic laboratory tests for infectious diseases.

Talis Biomedical Headquarters Location

230 Constitution Dr.

Menlo Park, California, 94025,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Talis Biomedical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Talis Biomedical is included in 7 Expert Collections, including Medical Devices.


Medical Devices

9,145 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

10,176 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.


Health Monitoring & Diagnostics

702 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Talis Biomedical Patents

Talis Biomedical has filed 24 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Medical tests
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Biotechnology, Chlamydiae, DNA, Infectious causes of cancer


Application Date


Grant Date



Related Topics

Molecular biology, Biotechnology, Chlamydiae, DNA, Infectious causes of cancer



Talis Biomedical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Talis Biomedical Rank

  • When was Talis Biomedical founded?

    Talis Biomedical was founded in 2010.

  • Where is Talis Biomedical's headquarters?

    Talis Biomedical's headquarters is located at 230 Constitution Dr., Menlo Park.

  • What is Talis Biomedical's latest funding round?

    Talis Biomedical's latest funding round is IPO.

  • How much did Talis Biomedical raise?

    Talis Biomedical raised a total of $10M.

  • Who are the investors of Talis Biomedical?

    Investors of Talis Biomedical include National Institutes of Health, National Institute of Allergy and Infectious Diseases and CARB-X.

  • Who are Talis Biomedical's competitors?

    Competitors of Talis Biomedical include Visby Medical, Cardea Bio, Baebies, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding and 22 more.

You May Also Like

Inflammatix Logo

Inflammatix is a molecular diagnostics company that develops rapid tests that read the immune system to resolve major clinical and public health challenges. The company's initial focus is on acute bacterial, viral infections, and sepsis.

Torus Biosystems Logo
Torus Biosystems

Torus Biosystems performs testing of DNA for scientific and medical research purposes.

Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

Ellume Logo

Ellume is a digital diagnostics company that develops and commercializes connected products for healthcare professionals and consumers. The company has developed a new biosensor technology that features unique optoelectronics and biologics.

Weavr Health Logo
Weavr Health

Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare.The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.

Binx Health Logo
Binx Health

Binx Health is an in vitro diagnostics Point-of-Care (POC) company that provides at-home STI testing. The platform also includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.